Results 111 to 120 of about 12,522 (211)

Clinical Features, Outcomes, and Antifungal Susceptibility Profiles of Invasive Candida Infections in a Tertiary Care Hospital in China

Infection and Drug Resistance
Dongting Yao,1,2,* Jia Chen,3,* Guanyi Zhang3 1Department of Laboratory Medicine, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200030, People’s Republic of China;
Yao D, Chen J, Zhang G
doaj  

Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins [PDF]

, 2017
Introduction. Invasive infections caused by Candida spp. in critically ill patients may significantly worsen their prognosis, so it is of great importance to establish an early detection and a suitable therapeutic strategy.
Grau, Santiago, Javier Candel, Francisco, Maseda, Emilio, Almirante, Benito, Guinea, Jesus, Munoz, Patricia, Garnacho-Montero, Jose, Ruiz Santana, Sergio, Moreno, Ignacio   +8 more
core  

In Vitro Activity of Rezafungin Against Planktonic and Biofilm Forms of Candida albicans and Nakaseomyces glabratus Clinical Isolates from Vascular Infections in Poland: A Pilot Study

Pharmaceutics
Background/Objectives: Certain yeast species are recognized as significant opportunistic pathogens, capable of causing severe systemic infections, particularly in immunocompromised individuals or those with disrupted physiological barriers.
Iwona Skiba-Kurek, Magdalena Namysł, Katarzyna Kania, Joanna Czekajewska, Anna Sepioło, Tomasz Gosiewski, Aldona Olechowska-Jarząb   +6 more
doaj   +1 more source

Impact of Obesity on Echinocandin Effectiveness in Treating Candida Infections: A Retrospective Observational Cohort Study

Infection and Drug Resistance
Ahmad Aljohani,1,2,* Saeed Alqahtani3,* 1Pharmaceutical Care Services, King Fahd General Hospital, Ministry of Health, Jeddah, Saudi Arabia; 2Department of Pharmacy, College of Pharmacy, Nursing and Medical Sciences, Riyadh Elm University, Riyadh,
Aljohani A, Alqahtani S
doaj  

Global surveillance of <i>Candida albicans</i>: MIC distributions, resistance patterns, and temporal trends from the Antimicrobial Testing Leadership and Surveillance program (2015-2024). [PDF]

Antimicrob Agents Chemother
Cai G, Zhang Z.
europepmc   +1 more source

Therapeutic Challenges in Case of Trichophyton indotineae Dermatophytosis, Singapore, 2025. [PDF]

Emerg Infect Dis
Foo TJ, Koh MCY, Chew KL, Juay L, Wu SJ.
europepmc   +1 more source

<i>Candidozyma auris</i> susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents. [PDF]

JAC Antimicrob Resist
Klamer KS, Bhargava A, Johnson L, Sharma M, Saravolatz LD.   +4 more
europepmc   +1 more source

Multicenter evaluation of low inoculum and a colorimetric assay for antifungal susceptibility testing of <i>Aspergillus fumigatus</i> to echinocandins with the EUCAST E.Def 9.4. [PDF]

J Clin Microbiol
Meletiadis J, Siopi M, Meinike Jørgensen K, Escribano P, Guinea J, Arendrup MC.   +5 more
europepmc   +1 more source

Mutational landscape and molecular bases of echinocandin resistance in Saccharomyces cerevisiae. [PDF]

Genetics
Durand R, Torbey AG, Giguere M, Pageau A, Dubé AK, Lagüe P, Landry CR.   +6 more
europepmc   +1 more source

The Upcoming Antifungal Drugs in Clinical Development for the Treatment of Invasive Candidiasis. [PDF]

Infect Drug Resist
Zubovskaia A, Vazquez JA.
europepmc   +1 more source